Date Filed | Type | Description |
04/22/2011 |
BW
| Inspire Postpones Annual Meeting of Stockholders Due to Recently Announced Tender Offer |
04/08/2011 |
BW
| The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH |
04/07/2011 |
BW
| Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Inspire Pharmaceuticals, Inc. - ISPH |
04/07/2011 |
BW
| The Law Firm of Weiss & Lurie Investigates the Acquisition of Inspire Pharmaceuticals, Inc. |
04/06/2011 |
BW
| Law Office of Brodsky & Smith, LLC Announces Investigation of Inspire Pharmaceuticals, Inc. |
04/06/2011 |
BW
| The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH |
04/06/2011 |
BW
| Briscoe Law Firm and Powers Taylor LLP Investigate Inspire Pharmaceuticals, Inc. for Shareholders Concerning Merck Acquisition |
04/05/2011 |
BW
| The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH |
02/24/2011 |
BW
| Inspire Announces Webcast of Presentation at Citi Global Healthcare Conference |
02/17/2011 |
BW
| Inspire Reports Fourth Quarter and Full Year 2010 Financial Results |
02/17/2011 |
BW
| Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business |
02/14/2011 |
BW
| Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results and Provide Corporate Update |
12/13/2010 |
BW
| Inspire Announces Launch of DIQUASTM by Santen in Japan |
11/04/2010 |
BW
| Inspire Reports Third Quarter 2010 Financial Results |
10/21/2010 |
MW
| Inspire Announces Date for Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results |
10/21/2010 |
BW
| Data Presentations at North American Cystic Fibrosis Conference Highlight Denufosol's Novel Mechanism of Action |
09/17/2010 |
BW
| Data to Be Presented at ERS Conference Highlights Potential for Denufosol to Benefit Cystic Fibrosis Patients on Minimal Pharmacotherapy |
09/08/2010 |
BW
| Inspire Announces Webcast of Presentation at Stifel Nicolaus Healthcare Conference |
08/25/2010 |
BW
| Inspire Announces Amendment to Ophthalmic Collaboration |
08/13/2010 |
BW
| Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer |
07/22/2010 |
BW
| Inspire Announces Date for Conference Call and Webcast to Discuss Second Quarter 2010 Financial Results |
07/01/2010 |
BW
| Inspire Announces Management Structure Changes |
06/03/2010 |
BW
| Inspire Announces Webcasts of Presentations at Needham Healthcare Conference and Jefferies Life Sciences Conference |
05/03/2010 |
BW
| Inspire Reports First Quarter 2010 Financial Results |
04/27/2010 |
BW
| Inspire Announces Webcast of Presentation at Deutsche Bank Health Care Conference |
04/19/2010 |
BW
| Inspire Announces Date for Conference Call and Webcast to Discuss First Quarter 2010 Financial Results |
04/16/2010 |
BW
| Santen and Inspire Announce Approval of DIQUASTM for Dry Eye Treatment in Japan |
04/13/2010 |
BW
| Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer |
03/15/2010 |
BW
| Inspire Announces Results From AZASITE® Phase 2 Blepharitis Trials and Plans to Continue Clinical Development in Anterior and Posterior Blepharitis |
03/04/2010 |
BW
| Inspire Reports Fourth Quarter and Full Year 2009 Financial Results |
03/02/2010 |
BW
| Inspire Announces Webcast of Presentation at Cowen Health Care Conference |
03/01/2010 |
BW
| Inspire Elects George Abercrombie to Board of Directors |
02/26/2010 |
BW
| Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2009 Financial Results |
02/23/2010 |
BW
| Inspire Announces Grants Under NASDAQ Marketplace Rule 5635 |